Hyperuricemia, gout and comorbidity
Hyperuricemia is most often combined with lipid metabolism disorders, modifiable risk factors for coronary heart disease, stroke, abdominal obesity, type 2 diabetes mellitus, arterial hypertension, urolithiasis, chronic kidney disease. Current data indicate the presence of pro-inflammatory, pro-oxid...
Saved in:
| Main Authors: | N. A. Shostak, N. G. Pravdyuk, T. K. Loginova, G. N. Lazarenko |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2023-01-01
|
| Series: | Klinicist |
| Subjects: | |
| Online Access: | https://klinitsist.abvpress.ru/Klin/article/view/511 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Study on the Frequency and Factors Affecting Treatment Discontinuation in Gout Patients in Sari, 2023–2024
by: Yasaman Salehi, et al.
Published: (2025-03-01) -
Microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout. Part 2: gout therapy and the gut microbiota
by: M. S. Eliseev, et al.
Published: (2022-12-01) -
Pharmacotherapy of gout – modern approaches and prospects
by: P. A. Lebedev, et al.
Published: (2021-08-01) -
Current issues in the practical use of allopurinol in patients with gout and hyperuricemia
by: M. S. Eliseev
Published: (2024-10-01) -
The use of febuxostat in comorbid patients with gout in real clinical practice: own data
by: E. V. Zonova, et al.
Published: (2022-06-01)